{"schema_version":"secwatch.filing_event.v1","accession":"0001185185-21-001333","form_type":"8-K","ticker":"STEX","cik":"0001530766","company_name":"Streamex Corp.","filed_at":"2021-09-22T23:59:59+00:00","discovered_at":"2026-05-14T18:04:18.466956+00:00","generated_at":"2026-06-29T02:03:14.298522+00:00","sec_items":["5.02","8.01","9.01"],"event_type":"leadership","sentiment":"positive","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"BioSig appoints med device veteran James Barry as independent director","bullets":["James J. Barry, Ph.D., appointed to Board effective Sept 20, 2021, filling expanded 7-member board.","Dr. Barry has 30+ years in med devices; former SVP at Boston Scientific, President/CEO at InspireMD and Arsenal Medical.","Received 50,000 RSUs—50% vested immediately, 50% on first anniversary.","Over 60 physicians have completed 1,300+ patient cases with PURE EP system across 12 clinical sites.","Commercial launch focused in Northeast, Texas, Florida; in use at Mayo Clinic and St. David's Medical Center."],"urls":{"canonical":"https://secwatch.observer/filing/0001185185-21-001333","json":"https://secwatch.observer/filing/0001185185-21-001333.json","markdown":"https://secwatch.observer/filing/0001185185-21-001333.md","text":"https://secwatch.observer/filing/0001185185-21-001333.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1530766/000118518521001333/0001185185-21-001333-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1530766/000118518521001333/biosig20210921_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-29T02:03:14.298522+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"ee7cc87e83","claim":"James J. Barry was appointed as director at Streamex Corp..","evidence_excerpt":"On September 20, 2021, the board of directors (the “Board”) of BioSig Technologies, Inc. (the “Company”) appointed James J. Barry, Ph.D. as a director of the Company, effective as of the same date","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1530766/000118518521001333/0001185185-21-001333-index.htm","confidence":1.0,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}